期刊文献+

乳核内消液辅助乳腺癌术后化疗对患者临床疗效、生活质量的影响 被引量:3

Effects of Ruheneixiao Liquid Assisted Breast Cancer Postoperative Chemotherapy on Patients with Clinical Effect and Quality of Life
下载PDF
导出
摘要 目的:探讨乳核内消液辅助乳腺癌手术后化疗对患者疗效、化疗毒副作用及生存质量的影响。方法:107例乳腺癌术后实施化疗的患者分为试验组和对照组,各53例,两组患者均与乳腺癌手术后化疗,试验组同时采用乳核内消液进行辅助治疗,观察两组预后、化疗过程中的毒副作用及随访期间的生存质量差异。结果:两组3年生存率、5年生存率、5年生存中位时间比较差异均不具有统计学意义(P>0.05)。试验组血液系统毒性发生率、心脏毒性发生率均显著低于照组(P<0.05)。试验组躯体功能评分、认知功能评分、情绪功能评分均显著的高于对照组(P<0.05);试验组疲劳症状评分、恶心及呕吐评分、疼痛评分均显著低于对照组(P<0.05)。结论:乳核内消液辅助乳腺癌手术后化疗对患者的远期预后影响作用尚不明显,但对患者的毒副反应及生存质量改善具有积极作用。 Objective: To discuss ruheneixiao liquid assisted after breast cancer surgery chemotherapy of patients,chemotherapy side effects and quality of life influence.Methods: 107 patients with breast cancer after operation implementation in chemotherapy patients were divided into test group and control group,53 cases in each,two groups of patients were with chemotherapy after breast cancer surgery,experimental group at the same time,the nucleus eliminating liquid adjuvant therapy,observe differences in the quality of life during the toxic and side effects and follow-up in the course of chemotherapy and the prognosis of the two groups.Results: The groups of two,3 year survival rate,5 year survival rate,5 year survival time comparison difference were not statistically significant(P〈0.05).In the experimental group,the incidence of toxicity and the incidence of cardiac toxicity were significantly lower than those in the control group(P〈0.05).Test group physical function score,cognitive function score,emotional functioning ratings were significantly higher than control group(P〈0.05); test group,fatigue symptom score,nausea and vomiting,pain score were significantly lower than control group(P〈0.05).Conclusion: Nucleus eliminating liquid assisted surgery for breast cancer after chemotherapy for patients with long-term prognosis effect is not obvious,but toxicity and quality of life of the patients improved plays a positive role.
出处 《中国医药导刊》 2016年第4期347-348,350,共3页 Chinese Journal of Medicinal Guide
关键词 乳核内消液 乳腺癌 化疗 毒副作用 生存质量 Ruheneixiao liquid Breast Cancer Chemotherapy Toxicity Quality of Life
  • 相关文献

参考文献9

二级参考文献47

  • 1李玺,姜华,郭卫平,邱万寿,黄勇,吴珏堃,刘瑞磊,黄泽楠,刘仁斌.卡培他滨引起的手足综合征发病特点与治疗观察[J].中华临床医师杂志(电子版),2011,5(6):1781-1783. 被引量:19
  • 2周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,1998.331.
  • 3孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生社出版.2007.152.
  • 4Ronit Peled. Breast cancer, psychological distress and life events amongyoung women[ J]. British joumal BMC cancer,2008,8 (8) :245.
  • 5Beuth J, Schneider B, Schierholz JM. Impact of complementary treat- ment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study. Anticancer Res, 2008, 28 ( 1 B) :523 - 7..
  • 6Grossarth - Maticek R, Ziegler R. Randomized and non - randomized prospective controlled cohort studies in matched - pair design for the long -term therapy of breast cancer patients with a mistletoe preparation (Iscador) : a re - analysis. Eur J Med Res, 2006,11 ( 11 ) : 485 - 95.
  • 7Ammar EM,Said SA,Suddek GM,El-Damarawy SL.Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats. Canadian Journal of Physiology and Pharmacology . 2011
  • 8Masaaki Takeuchi,Hiromi Nakai,Michiko Kokumai,Tomoko Nishikage,Shinichiro Otani,Roberto M. Lang.Age-related Changes in Left Ventricular Twist Assessed by Two-dimensional Speckle-tracking Imaging[J].Journal of the American Society of Echocardiography.2006(9)
  • 9Steger GG,Bartsch. R. Trends and novel approaches inneoadjuvant treatment of breast cancer [J]. Breast Care(Basel),2011,6(6) :427-433.
  • 10Zapf I,Tizedes G, Pavlovics G, et al. Primary systemictherapy in breast cancer patients (2007-2010) [J]. MagySeb,2011,64(5):223-228.

共引文献93

同被引文献45

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部